Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein.

Chasman DI, Kozlowski P, Zee RY, Kwiatkowski DJ, Ridker PM.

Genes Immun. 2006 Apr;7(3):211-9.

PMID:
16511556
2.

Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults.

Viiri LE, Raitakari OT, Huhtala H, Kähönen M, Rontu R, Juonala M, Hutri-Kähönen N, Marniemi J, Viikari JS, Karhunen PJ, Lehtimäki T.

J Lipid Res. 2006 Jun;47(6):1298-306. Epub 2006 Mar 9.

3.

The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.

Vaisi-Raygani A, Rahimi Z, Nomani H, Tavilani H, Pourmotabbed T.

Clin Biochem. 2007 Oct;40(15):1150-6. Epub 2007 Jul 6.

PMID:
17689519
4.

Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.

Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengârd JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF.

Am J Hum Genet. 2000 Oct;67(4):881-900. Epub 2000 Sep 13.

5.

ApoE plasma levels and risk of cardiovascular mortality in old age.

Mooijaart SP, Berbée JF, van Heemst D, Havekes LM, de Craen AJ, Slagboom PE, Rensen PC, Westendorp RG.

PLoS Med. 2006 Jun;3(6):e176. Epub 2006 May 9.

6.

Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism.

Stengård JH, Clark AG, Weiss KM, Kardia S, Nickerson DA, Salomaa V, Ehnholm C, Boerwinkle E, Sing CF.

Am J Hum Genet. 2002 Sep;71(3):501-17. Epub 2002 Aug 5.

7.

Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population.

Masemola ML, Alberts M, Urdal P.

Scand J Public Health Suppl. 2007 Aug;69:60-5.

PMID:
17676504
8.

Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study.

Corella D, Tucker K, Lahoz C, Coltell O, Cupples LA, Wilson PW, Schaefer EJ, Ordovas JM.

Am J Clin Nutr. 2001 Apr;73(4):736-45.

9.

Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants.

Volcik KA, Barkley RA, Hutchinson RG, Mosley TH, Heiss G, Sharrett AR, Ballantyne CM, Boerwinkle E.

Am J Epidemiol. 2006 Aug 15;164(4):342-8. Epub 2006 Jun 7.

10.

Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients.

Morbois-Trabut L, Chabrolle C, Garrigue MA, Lasfargues G, Lecomte P.

Diabetes Metab. 2006 Jun;32(3):270-5.

11.

Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.

Elovainio M, Puttonen S, Pulkki-Råback L, Kivimaki M, Viiri LE, Lehtimaki T, Karhunen P, Viikari J, Raitakari OT, Keltikangas-Jarvinen L.

Neuropsychobiology. 2008;58(2):91-6. doi: 10.1159/000162355. Epub 2008 Oct 9.

PMID:
18843194
12.

Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.

Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX, Hatseras DI, Kaski JC.

J Am Coll Cardiol. 2006 Dec 19;48(12):2471-81. Epub 2006 Nov 22.

13.

Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.

Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS.

Chin Med J (Engl). 2005 Apr 5;118(7):555-60.

PMID:
15820086
14.

Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans.

Austin MA, Zhang C, Humphries SE, Chandler WL, Talmud PJ, Edwards KL, Leonetti DL, McNeely MJ, Fujimoto WY.

Ann Hum Genet. 2004 May;68(Pt 3):179-88.

15.

Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y; Japanese Genetic Study Consortium for Alzeheimer's Disease.

Hum Mol Genet. 2006 Jul 1;15(13):2170-82. Epub 2006 Jun 1.

16.

ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome.

Olivieri O, Martinelli N, Bassi A, Trabetti E, Girelli D, Pizzolo F, Friso S, Pignatti PF, Corrocher R.

Clin Exp Med. 2007 Dec;7(4):164-72. doi: 10.1007/s10238-007-0142-y. Epub 2008 Jan 11.

PMID:
18188530
17.

Apolipoprotein E polymorphism in the Greek population.

Sklavounou E, Economou-Petersen E, Karadima G, Panas M, Avramopoulos D, Varsou A, Vassilopoulos D, Petersen MB.

Clin Genet. 1997 Oct;52(4):216-8.

PMID:
9383026
18.
19.

Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.

Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, O'Donnell CJ, Hirschhorn JN, Benjamin EJ.

Circulation. 2006 Mar 21;113(11):1415-23. Epub 2006 Mar 13.

20.

Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters.

Liang S, Pan M, Geng HH, Chen H, Gu LQ, Qin XT, Qian JJ, Zhu JH, Liu CF.

Mol Biol Rep. 2009 Jul;36(6):1251-6. doi: 10.1007/s11033-008-9305-5. Epub 2008 Jul 4.

PMID:
18600472
Items per page

Supplemental Content

Write to the Help Desk